This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
ICL or NVZMY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ICL vs. NVZMY: Which Stock Is the Better Value Option?
ICL vs. NVZMY: Which Stock Is the Better Value Option?
by Zacks Equity Research
ICL vs. NVZMY: Which Stock Is the Better Value Option?
ICL or FOE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ICL vs. FOE: Which Stock Is the Better Value Option?
Israel Chemicals (ICL) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Israel Chemicals (ICL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
ICL vs. ECL: Which Stock Is the Better Value Option?
by Zacks Equity Research
ICL vs. ECL: Which Stock Is the Better Value Option?
Israel Chemicals (ICL) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Israel Chemicals (ICL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
ICL vs. ECL: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ICL vs. ECL: Which Stock Is the Better Value Option?
Is Israel Chemicals (ICL) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Israel Chemicals (ICL) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Israel Chemicals (ICL) Q4 Earnings In Line, Revenues Down Y/Y
by Zacks Equity Research
Disruptions associated with the potash capacity upgrade of the Dead Sea facilities impacted Israel Chemicals' (ICL) Q4 results.
Chemical Stock Earnings Due on Nov 7: APD, ESI, TROX & ICL
by Anindya Barman
Let's take a look at how these chemical companies are poised ahead of their earnings release.
ICL or FUL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ICL vs. FUL: Which Stock Is the Better Value Option?
US Chemical Production Dips in August on Broad-Based Declines
by Anindya Barman
The August reading showed a decline in U.S. chemical production on both monthly and year-over-year comparison basis across all regions.
Manufacturing Rebound Drives US Specialty Chemicals: 4 Picks
by Anindya Barman
We highlight four specialty chemical stocks that are worth considering for investment right now.
Is Israel Chemicals (ICL) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Axalta Coating Systems (AXTA) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Axalta Coating Systems (AXTA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Chemicals Hit by Tariffs, But These 4 Stocks Are Worth a Bet
by Anindya Barman
We have highlighted four stocks in the chemical space that have compelling prospects and are well poised for an upside.
Is Israel Chemicals (ICL) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Chemicals Off to a Sluggish Start in Q3, Output Eases in July
by Anindya Barman
Global chemical production fell 0.1% on a monthly basis in July on lower capacity utilization.
Weak Start for U.S. Specialty Chemicals in Q3: Tariffs a Woe
by Anindya Barman
The specialty chemical industry has been bruised by escalating Sino-U.S. trade tensions.
Is Israel Chemicals (ICL) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
ICL or NGVT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ICL vs. NGVT: Which Stock Is the Better Value Option?
Is Israel Chemicals (ICL) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
DuPont's (DD) Earnings Top, Sales Trail Estimates in Q2
by Zacks Equity Research
DuPont (DD) gains from cost and pricing actions in Q2. The company raises adjusted earnings per share guidance for 2019.
Olin's (OLN) Q2 Earnings In Line, Revenues Beat Estimates
by Zacks Equity Research
Olin (OLN) witnessed continued weakness in caustic soda pricing in the second quarter.